Seven months clear from the injury that cost him part of his 2024 season, is there reason to worry that Lions' Aidan Hutchinson can't return to form?

Capricor Therapeutics leads with Deramiocel for DMD and StealthX tech, backed by trials, NS Pharma deal, and cash. See why ...

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg have identified a previously undocumented, organ-specific toxicity linked to CD19-targeted CAR T-cell therapy in autoimmune disease.